India's Finance Ministry recently gave notice that certain companies would be allowed to relabel their drugs to reflect pricing changes at designated locations other than their manufacturing facilities--a special exemption that is already confusing companies and consumers alike. India is implementing new cost ceilings, which must be reflected on labels within 45 days of a drug's revised price listing. Now, according to The Hindu Business Line, companies can alter their labels with greater ease, and those that do so can avoid an additional excise tax. But, as the newspaper notes, some companies are unclear on whether the new notice allows them an additional 45-day window for updating their pricing. And as confusion delays drugmakers' compliance, some consumers aren't benefiting from the price reductions. Story